|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Land | ||||||||||||||||||||
| Depreciable property | ||||||||||||||||||||
| Projects under development | ||||||||||||||||||||
| Land held for development | ||||||||||||||||||||
| Investment in real estate | ||||||||||||||||||||
| Accumulated depreciation | ||||||||||||||||||||
| Investment in real estate, net | ||||||||||||||||||||
| Investments in unconsolidated entities | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted deposits | ||||||||||||||||||||
| Right-of-use assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Mortgage notes payable, net | ||||||||||||||||||||
| Notes, net | ||||||||||||||||||||
| Line of credit and commercial paper | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Lease liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Security deposits | ||||||||||||||||||||
| Distributions payable | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Redeemable Noncontrolling Interests – Operating Partnership | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Shareholders' equity: | ||||||||||||||||||||
| Preferred Shares of beneficial interest, $0.01 par value; 100,000,000 shares authorized; 343,100 shares issued and outstanding as of June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common Shares of beneficial interest, $0.01 par value; 1,000,000,000 shares authorized; 374,893,890 shares issued and outstanding as of June 30, 2026 and 377,806,173 shares issued and outstanding as of December 31, 2025 | ||||||||||||||||||||
| Paid in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Noncontrolling Interests: | ||||||||||||||||||||
| Operating Partnership | ||||||||||||||||||||
| Partially Owned Properties | ||||||||||||||||||||
| Total Noncontrolling Interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity/capital |
Loading...
